Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals
- 1 November 2009
- journal article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 161 (5), 795-798
- https://doi.org/10.1530/eje-09-0412